Shu Yi Shen

University Health Network — Canada

Biochemistry, Genetics and Molecular Biology · Life Sciences

17h-index4.1kcitations87works2.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Genomics and Diagnostics(49), Epigenetics and DNA Methylation(29), Head and Neck Cancer Studies(23), Tumors and Oncological Cases(20), RNA modifications and cancer(14)

Publications87 total

Chromatin accessibility landscapes define stromal cell identities across tissues
Communications Biology·2026Open Access
Evolutionary dynamics of recurrent hepatocellular carcinoma under divergent immune selection pressures
Frontiers in Oncology·2025Open Access
Abstract 3249: The development of a tissue-agnostic genome-wide methylome enrichment assay for lung cancer
Cancer Research·2025
Figure S5 from Chronic Viral Mimicry Induction following p53 Loss Promotes Immune Evasion
2025Open Access
Figure S7 from Chronic Viral Mimicry Induction following p53 Loss Promotes Immune Evasion
2025Open Access
Figure S3 from Chronic Viral Mimicry Induction following p53 Loss Promotes Immune Evasion
2025Open Access
Data from Chronic Viral Mimicry Induction following p53 Loss Promotes Immune Evasion
2025Open Access
Figure S6 from Chronic Viral Mimicry Induction following p53 Loss Promotes Immune Evasion
2025Open Access
Table S4 from Chronic Viral Mimicry Induction following p53 Loss Promotes Immune Evasion
2025Open Access
Table S2 from Chronic Viral Mimicry Induction following p53 Loss Promotes Immune Evasion
2025Open Access
Figure S1 from Chronic Viral Mimicry Induction following p53 Loss Promotes Immune Evasion
2025Open Access
Figure S4 from Chronic Viral Mimicry Induction following p53 Loss Promotes Immune Evasion
2025Open Access
Table S1 from Chronic Viral Mimicry Induction following p53 Loss Promotes Immune Evasion
2025Open Access
Figure S2 from Chronic Viral Mimicry Induction following p53 Loss Promotes Immune Evasion
2025· 1 citedOpen Access
Table S3 from Chronic Viral Mimicry Induction following p53 Loss Promotes Immune Evasion
2025Open Access
Chronic Viral Mimicry Induction following p53 Loss Promotes Immune Evasion
Cancer Discovery·2025· 15 citedOpen Access
64O Clinical validation of a tissue-agnostic genome-wide methylome enrichment assay for MRD in head and neck cancers
Annals of Oncology·2024· 1 citedOpen Access
Epigenomic Prognosis: Predicting fetal growth restriction beyond ultrasound markers
Placenta·2024Open Access
Effect of nucleos(t)ide analogue discontinuation on the prognosis of <scp>HBeAg</scp>‐negative hepatitis B virus‐related hepatocellular carcinoma after hepatectomy: A propensity score matching analysis
Cancer Medicine·2024Open Access
Performance characteristics of a tissue-agnostic genome-wide methylome enrichment MRD assay for head and neck malignancies.
Journal of Clinical Oncology·2024
page 1 of 5Next →

Frequent Co-authors

Daniel D. De Carvalho(35), Scott V. Bratman(17), Michael M. Hoffman(14), Justin Burgener(14), Geoffrey Liu(13), Ankur Chakravarthy(12), Anna Spreafico(10), Helen Loo Yau(9), Shao Hui Huang(9), Lillian L. Siu(9), Tiago da Silva Medina(8), Ilias Ettayebi(8), Jinfeng Zou(8), Sareh Keshavarzi(8), Fei‐Fei Liu(8), John Waldron(8), Ilan Weinreb(8), John R. de Almeida(8), David P. Goldstein(8), Charles A. Ishak(8)